Interleukin-6: a novel target for cardio-cerebrovascular diseases

JH Su, MY Luo, N Liang, SX Gong, W Chen… - Frontiers in …, 2021‏ - frontiersin.org
Cardio-Cerebrovascular Disease is a collective term for cardiovascular disease and
cerebrovascular disease, being a serious threat to human health. A growing number of …

Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy

JE McLaren, DR Michael, TG Ashlin, DP Ramji - Progress in lipid research, 2011‏ - Elsevier
Cardiovascular disease is the biggest killer globally and the principal contributing factor to
the pathology is atherosclerosis; a chronic, inflammatory disorder characterized by lipid and …

Vascular inflammation and the renin-angiotensin system

AR Brasier, A Recinos III, MS Eledrisi - … , thrombosis, and vascular …, 2002‏ - ahajournals.org
It is now well established that vascular inflammation is an independent risk factor for the
development of atherosclerosis. In otherwise healthy patients, chronic elevations of …

[HTML][HTML] Chronic stress impacts the cardiovascular system: animal models and clinical outcomes

S Golbidi, JC Frisbee, I Laher - American Journal of …, 2015‏ - journals.physiology.org
Psychological stresses are associated with cardiovascular diseases to the extent that
cardiovascular diseases are among the most important group of psychosomatic diseases …

How much is too much? Interleukin-6 and its signalling in atherosclerosis

H Schuett, M Luchtefeld, C Grothusen… - Thrombosis and …, 2009‏ - thieme-connect.com
The importance of inflammation as a driver of pathology is no longer confined to
autoimmune and infectious diseases. In line with convincing experimental data as well as …

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture

JJ Boyle - Current vascular pharmacology, 2005‏ - benthamdirect.com
Atherosclerosis is still an important disease. It accounts for 39% of deaths in the UK and 12
million US citizens have atherosclerosis-associated disease. Atherosclerosis may exert …

Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications

K Tikoo, G Patel, S Kumar, PA Karpe… - Biochemical …, 2015‏ - Elsevier
Growing body of evidence points out the crucial role of ACE2 in preventing atherosclerosis.
However, data on how atherosclerosis affects ACE2 expression in heart and kidney remains …

Angiotensin-converting enzyme and vascular remodeling

S Heeneman, JC Sluimer, MJAP Daemen - Circulation research, 2007‏ - ahajournals.org
Vascular remodeling is the result of a close interplay of changes in vascular tone and
structure. In this review, the role of angiotension-converting enzyme (ACE) and the impact of …

Novel anti-inflammatory therapies for the treatment of atherosclerosis

R Khan, V Spagnoli, JC Tardif, PL L'Allier - Atherosclerosis, 2015‏ - Elsevier
The underlying role of inflammation in atherosclerosis has been characterized. However,
current treatment of coronary artery disease (CAD) predominantly consists of targeted …

Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?

AB Reiss, NM Siegart, J De Leon - Clinical Lipidology, 2017‏ - Taylor & Francis
ABSTRACT Interleukin-6 (IL-6) is a unique pleiotropic cytokine exhibiting both pro-and anti-
inflammatory properties depending on the target cell type. Plasma IL-6 levels are associated …